These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9696930)

  • 1. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group.
    Bartsch H; Malaveille C; Lowenfels AB; Maisonneuve P; Hautefeuille A; Boyle P
    Eur J Cancer Prev; 1998 Jun; 7(3):215-23. PubMed ID: 9696930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analyses of genetic polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR with chronic alcoholic pancreatitis in Japan.
    Maruyama K; Harada S; Yokoyama A; Mizukami S; Naruse S; Hirota M; Nishimori I; Otsuki M
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S34-8. PubMed ID: 18986377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
    Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
    Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
    van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
    Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.
    Gallou C; Longuemaux S; Deloménie C; Méjean A; Martin N; Martinet S; Palais G; Bouvier R; Droz D; Krishnamoorthy R; Junien C; Béroud C; Dupret JM
    Pharmacogenetics; 2001 Aug; 11(6):521-35. PubMed ID: 11505222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study.
    Tiemersma EW; Kampman E; Bueno de Mesquita HB; Bunschoten A; van Schothorst EM; Kok FJ; Kromhout D
    Cancer Causes Control; 2002 May; 13(4):383-93. PubMed ID: 12074508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.